Both in Biotechnology
Krystal Biotech vs Kymera Therapeutics
Over the past year KRYS returned +68.0% and KYMR returned +112.0%; their daily moves had a correlation of 0.30.
KRYS +68.0% KYMR +112.0%Growth of $1, one year, split-adjusted
| Metric | KRYS | KYMR |
|---|---|---|
| Price | $332.29 | $126.63 |
| Market cap | $9.84B | $10.81B |
| Today | +2.38% | +3.29% |
| 1 month | +2.1% | +15.0% |
| 6 months | +24.9% | +56.9% |
| Year to date | +34.8% | +62.7% |
| 1 year | +79.6% | +110.9% |
| Revenue growth (YoY) | +24.1% | −100.0% |
| Gross margin | 94.6% | — |
| Net margin | 45.9% | — |
| P/E (TTM) | 40.7× | — |
| Price / sales | 22.3× | 105.7× |
| Net cash | $845.6M | $969.2M |
| Dividend yield | — | — |
| Volatility (60d) | 30.6% | 38.9% |
| Short % of float | 12.9% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).